Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Kalra

Showing results (171-180 of 193) with videos related to

Pageof 20
Sort By:
Nature Medicine|March 30, 2025
Systematic review and meta-analysis of intravenous iron therapy for patients with heart failure and iron deficiencyStefan D Anker, Mahir Karakas, Robert J Mentz, et al.
European Journal of Heart Failure|July 30, 2024
Administration of ferric derisomaltose for iron deficiency and heart failure during hospital admission or at the clinic - insights from the IRONMAN trialMatthew M Y Lee, Mark C Petrie, John G F Cleland, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 7, 2023
A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studiesJoanna Osmanska, Katriona Brooksbank, Kieran F Docherty, et al.
Journal of the American College of Cardiology|February 4, 2012
Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trialStephan von Haehling, Joerg C Schefold, Ewa A Jankowska, et al.
Journal of Cardiac Failure|November 5, 2023
The Impact of Ferric Derisomaltose on Cardiovascular and Noncardiovascular Events in Patients With Anemia, Iron Deficiency, and Heart Failure With Reduced Ejection FractionRobin Ray, Ian Ford, John G F Cleland, et al.
Heart (British Cardiac Society)|August 10, 2022
Rationale and design of a randomised trial of intravenous iron in patients with heart failurePaul R Kalra, John Gf Cleland, Mark C Petrie, et al.
Physical Review Letters|January 15, 2011
Centrifugal separation of antiprotons and electronsG Gabrielse, W S Kolthammer, R McConnell, et al.
Heart (British Cardiac Society)|February 12, 2025
Age-stratified effects of intravenous ferric derisomaltose in heart failure with iron deficiency: insights from the IRONMAN trialShirley Sze, Iain Squire, Paul R Kalra, et al.
Circulation. Cardiovascular Imaging|October 26, 2018
Absence of Myocardial Fibrosis Predicts Favorable Long-Term Survival in New-Onset Heart FailureAnkur Gulati, Alan G Japp, Sadaf Raza, et al.
Toxicology and Industrial Health|January 24, 2003
Response of F344 rats to inhalation of subclinical levels of sarin: exploring potential causes of Gulf War illnessR F Henderson, E B Barr, W B Blackwell, et al.
Pageof 20

Showing results (171-180 of 193) with videos related to

Sort By:
Pageof 20
Nature Medicine|March 30, 2025
Systematic review and meta-analysis of intravenous iron therapy for patients with heart failure and iron deficiencyStefan D Anker, Mahir Karakas, Robert J Mentz, et al.
European Journal of Heart Failure|July 30, 2024
Administration of ferric derisomaltose for iron deficiency and heart failure during hospital admission or at the clinic - insights from the IRONMAN trialMatthew M Y Lee, Mark C Petrie, John G F Cleland, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 7, 2023
A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studiesJoanna Osmanska, Katriona Brooksbank, Kieran F Docherty, et al.
Journal of the American College of Cardiology|February 4, 2012
Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trialStephan von Haehling, Joerg C Schefold, Ewa A Jankowska, et al.
Journal of Cardiac Failure|November 5, 2023
The Impact of Ferric Derisomaltose on Cardiovascular and Noncardiovascular Events in Patients With Anemia, Iron Deficiency, and Heart Failure With Reduced Ejection FractionRobin Ray, Ian Ford, John G F Cleland, et al.
Heart (British Cardiac Society)|August 10, 2022
Rationale and design of a randomised trial of intravenous iron in patients with heart failurePaul R Kalra, John Gf Cleland, Mark C Petrie, et al.
Physical Review Letters|January 15, 2011
Centrifugal separation of antiprotons and electronsG Gabrielse, W S Kolthammer, R McConnell, et al.
Heart (British Cardiac Society)|February 12, 2025
Age-stratified effects of intravenous ferric derisomaltose in heart failure with iron deficiency: insights from the IRONMAN trialShirley Sze, Iain Squire, Paul R Kalra, et al.
Circulation. Cardiovascular Imaging|October 26, 2018
Absence of Myocardial Fibrosis Predicts Favorable Long-Term Survival in New-Onset Heart FailureAnkur Gulati, Alan G Japp, Sadaf Raza, et al.
Toxicology and Industrial Health|January 24, 2003
Response of F344 rats to inhalation of subclinical levels of sarin: exploring potential causes of Gulf War illnessR F Henderson, E B Barr, W B Blackwell, et al.
Pageof 20